Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development

被引:185
作者
Ruan, WF
Kleinberg, DL
机构
[1] NYU, Sch Med, Dept Med, New York, NY 10010 USA
[2] Dept Vet Affairs Med Ctr, Dept Med, New York, NY 10010 USA
关键词
D O I
10.1210/en.140.11.5075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies from this laboratory have emphasized the essential role of GH in pubertal mammary development and shown that insulin-like growth factor I (IGF-I) was capable of substituting for GH in this process in rats and mice. The present study shows that, even when GH is present, no mammary development is possible unless IGF-I is present. IGF-I(-/-) null female animals were found to have significantly less mammary development than age matched wild-type controls (P < 0.006) using several endpoints including the number of terminal end buds or TEBs (1.3 vs. 7.3), percent of the fat pad occupied by glandular elements (6.5 us. 100), and number of ducts (15 us. too numerous to count). That the deficiency in mammary gland development was related to the absence of IGF-I was underscored by the observation that des (1-3) IGF-I administration to IGF-I(-/-) null animals for 5 days caused significant mammary gland development as measured by TEE formation and branching of ducts. The number of TEBs rose from a mean of 1.3 in controls to 20.5 without added E-2 (P < 0.009), and from 1.7 to 21 when des (1-3) IGF-I was given together with E-2 (P < 0.006). The number of ducts increased significantly from a mean of 12 to 27 in response to IGF-I and E-2, and from 15 to 24.5 with IGF-I alone. In contrast, administration of human GH with E-2 had no stimulatory effect on mammary development in these animals, indicating that the full effect of GH in this process is mediated by IGF-I. To determine whether IGF-I was also responsible for further ductal morphogenesis, we administered des (1-3) IGF-I + E-2 to the knockout animals for 14 days and compared the effects of this combination of hormones on mammary development with those observed after 5 days. We found that there was a significant increase from 5 to 14 days in the number of TEBs (mean: 21 us. 41) and the area of the mammary fat pad occupied by glands (mean: 10 vs. 20%). There was elongation and thickening of the ducts which accounted for the increased area that was occupied by ductal structures. There was no significant increase in the number of ducts. However, there was the appearance of a large number of buds along the length of the ductal structures, suggesting the beginning of side branching. These results suggest that IGF-I, when given along with E-2, is responsible for ductal morphogenesis.
引用
收藏
页码:5075 / 5081
页数:7
相关论文
共 16 条
[1]   Effects of an Igf1 gene null mutation on mouse reproduction [J].
Baker, J ;
Hardy, MP ;
Zhou, J ;
Bondy, C ;
Lupu, F ;
Bellve, AR ;
Efstratiadis, A .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (07) :903-918
[2]  
DANIEL CW, 1987, MAMMARY GLAND DEV RE, P1
[3]   EVIDENCE THAT THE GROWTH-HORMONE RECEPTOR MEDIATES DIFFERENTIATION AND DEVELOPMENT OF THE MAMMARY-GLAND [J].
FELDMAN, M ;
RUAN, WF ;
CUNNINGHAM, BC ;
WELLS, JA ;
KLEINBERG, DL .
ENDOCRINOLOGY, 1993, 133 (04) :1602-1608
[4]  
Gardner WU, 1941, P SOC EXP BIOL MED, V48, P590, DOI 10.3181/00379727-48-13397
[5]   Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-Binding protein expression [J].
Hadsell, DL ;
Greenberg, NM ;
Fligger, JM ;
Baumrucker, CR ;
Rosen, JM .
ENDOCRINOLOGY, 1996, 137 (01) :321-330
[6]  
Kleinberg DL, 1999, ADV MOL CELL ENDOCR, V3, P227
[7]   NONLACTOGENIC EFFECTS OF GROWTH-HORMONE ON GROWTH AND INSULIN-LIKE GROWTH FACTOR-I MESSENGER-RIBONUCLEIC-ACID OF RAT MAMMARY-GLAND [J].
KLEINBERG, DL ;
RUAN, W ;
CATANESE, V ;
NEWMAN, CB ;
FELDMAN, M .
ENDOCRINOLOGY, 1990, 126 (06) :3274-3276
[8]   PRIMATE MAMMARY DEVELOPMENT - EFFECTS OF HYPOPHYSECTOMY, PROLACTIN INHIBITION, AND GROWTH-HORMONE ADMINISTRATION [J].
KLEINBERG, DL ;
NIEMANN, W ;
FLAMM, E ;
COOPER, P ;
BABITSKY, G ;
VALENSI, Q .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (06) :1943-1950
[9]  
LYONS WR, 1958, RECENT PROG HORM RES, V14, P219
[10]   Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model [J].
Neuenschwander, S ;
Schwartz, A ;
Wood, TL ;
Roberts, CT ;
Henninghausen, L ;
LeRoith, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2225-2232